These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7044950)

  • 1. CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed.
    Scher I
    Immunol Rev; 1982; 64():117-36. PubMed ID: 7044950
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity.
    Scher I
    Adv Immunol; 1982; 33():1-71. PubMed ID: 6215838
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect.
    Perlmutter RM; Nahm M; Stein KE; Slack J; Zitron I; Paul WE; Davie JM
    J Exp Med; 1979 Apr; 149(4):993-8. PubMed ID: 311819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional antigen binding by the defective B cells of CBA/N x C3H/HeN F1 male mice.
    Snippe H; Merchant B; Lizzio E; Inman JK
    J Immunogenet; 1980 Oct; 7(5):409-20. PubMed ID: 6968801
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.
    Slack J; Der-Balian GP; Nahm M; Davie JM
    J Exp Med; 1980 Apr; 151(4):853-62. PubMed ID: 6966310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked immune deficiency (xid) of CBA/N mice.
    Wicker LS; Scher I
    Curr Top Microbiol Immunol; 1986; 124():87-101. PubMed ID: 3486747
    [No Abstract]   [Full Text] [Related]  

  • 8. X-linked B lymphocyte defect in CBA/N mice. IV. Cellular and environmental influences on the thymus dependent IgG anti-sheep red blood cell response.
    Scher I; Berning AK; Asofsky R
    J Immunol; 1979 Jul; 123(1):477-86. PubMed ID: 376745
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the response of B cells from CBA/N-defective mice to nonspecific T cell help.
    Greenstein JL; Lord E; Kappler JW; Marrack PC
    J Exp Med; 1981 Nov; 154(5):1608-17. PubMed ID: 6975350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
    Scher I; Berning AK; Kessler S; Finkelman FD
    J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response and acquired resistance to Ascaris suum infection in mice with an X-linked B lymphocyte defect.
    Brown AR; Crandall CA; Crandall RB
    J Parasitol; 1977 Oct; 63(5):950-2. PubMed ID: 303286
    [No Abstract]   [Full Text] [Related]  

  • 12. The ontogeny and distribution of B cells in normal and mutant immune-defective CBA/N mice: two-parameter analysis of surface IgM and IgD.
    Scher I; Titus JA; Finkelman FD
    J Immunol; 1983 Feb; 130(2):619-25. PubMed ID: 6600246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of emerging repertoires by immunosuppression in immunodeficient mice results in autoimmunity.
    Marcos MA; de la Hera A; Gaspar ML; Márquez C; Bellas C; Mampaso F; Toribio ML; Martínez C
    Immunol Rev; 1986 Dec; 94():51-74. PubMed ID: 3100422
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility to in vitro tolerance induction of adult B cells from mice with an X-linked B-cell defect.
    Metcalf ES; Scher I; Klinman NR
    J Exp Med; 1980 Feb; 151(2):486-91. PubMed ID: 6965400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBA/N mice have marginal zone B cells with normal surface immunoglobulin phenotype.
    Liu YJ; Lortan JE; Oldfield S; MacLennan IC
    Adv Exp Med Biol; 1988; 237():105-11. PubMed ID: 3075843
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased numbers of spleen colony forming units in B cell deficient CBA/N mice.
    Wiktor-Jedrzejczak W; Krupienicz A; Scher I
    Strahlenther Onkol; 1986 Jun; 162(6):387-90. PubMed ID: 3488594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xid mice lack regulatory immunoglobulin, which contributes to the enhancement of SRBC responses.
    Simpson SD; Pecquet SS; Ernst PB
    Ann N Y Acad Sci; 1992 May; 651():179-81. PubMed ID: 1376038
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody-defective, genetically susceptible CBA/N mice have an altered Salmonella typhimurium-specific B cell repertoire.
    Duran LW; Metcalf ES
    J Exp Med; 1987 Jan; 165(1):29-46. PubMed ID: 2432151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DBA/2Ha mice as a model of an X-linked immunodeficiency which is defective in the expression of TRF-acceptor site(s) on B lymphocytes.
    Takatsu K; Hamaoka T
    Immunol Rev; 1982; 64():25-55. PubMed ID: 7044951
    [No Abstract]   [Full Text] [Related]  

  • 20. B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.
    Ahmed A; Scher I; Sharrow SO; Smith AH; Paul WE; Sachs DH; Sell KW
    J Exp Med; 1977 Jan; 145(1):101-10. PubMed ID: 299767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.